PL192890A1 - Sposob wytwarzania nowych 1-benzazoliloalkilo-4-podstawowych piperydyn - Google Patents
Sposob wytwarzania nowych 1-benzazoliloalkilo-4-podstawowych piperydynInfo
- Publication number
- PL192890A1 PL192890A1 PL19289076A PL19289076A PL192890A1 PL 192890 A1 PL192890 A1 PL 192890A1 PL 19289076 A PL19289076 A PL 19289076A PL 19289076 A PL19289076 A PL 19289076A PL 192890 A1 PL192890 A1 PL 192890A1
- Authority
- PL
- Poland
- Prior art keywords
- benzazolyloalkyl
- piperidines
- basic
- making new
- making
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62072775A | 1975-10-08 | 1975-10-08 | |
| US05/713,309 US4035369A (en) | 1975-10-08 | 1976-08-10 | 1-Benzazolylalkyl-4-substituted-piperidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL192890A1 true PL192890A1 (pl) | 1978-03-28 |
| PL106815B1 PL106815B1 (pl) | 1980-01-31 |
Family
ID=27088773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1976192890A PL106815B1 (pl) | 1975-10-08 | 1976-10-07 | Sposob wytwarzania nowych 1-benzazoliloalkilo-4-podstawionych piperydyn |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4035369A (pl) |
| JP (1) | JPS5246082A (pl) |
| AT (1) | AT365185B (pl) |
| AU (1) | AU511834B2 (pl) |
| BG (1) | BG27542A3 (pl) |
| CA (1) | CA1085853A (pl) |
| CH (1) | CH630915A5 (pl) |
| CS (1) | CS225101B2 (pl) |
| DE (1) | DE2645125A1 (pl) |
| DK (1) | DK151801C (pl) |
| EG (1) | EG12969A (pl) |
| ES (1) | ES452200A1 (pl) |
| FI (1) | FI63228C (pl) |
| FR (1) | FR2346009A1 (pl) |
| GB (1) | GB1532546A (pl) |
| GR (1) | GR61672B (pl) |
| HU (1) | HU174927B (pl) |
| IE (1) | IE43951B1 (pl) |
| IL (1) | IL50631A (pl) |
| IT (1) | IT1069293B (pl) |
| LU (1) | LU75954A1 (pl) |
| NL (1) | NL7611085A (pl) |
| NO (1) | NO144926C (pl) |
| NZ (1) | NZ182134A (pl) |
| PH (1) | PH15417A (pl) |
| PL (1) | PL106815B1 (pl) |
| PT (1) | PT65688B (pl) |
| RO (1) | RO69904A (pl) |
| SE (1) | SE417610B (pl) |
| SU (1) | SU663306A3 (pl) |
| YU (1) | YU39976B (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200641A (en) * | 1976-12-21 | 1980-04-29 | Janssen Pharmaceutica, N.V. | 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives |
| US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| IE810250L (en) * | 1980-02-11 | 1981-08-11 | Berlex Lab | N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines. |
| US4254127A (en) * | 1980-04-03 | 1981-03-03 | Janssen Pharmaceutica, N.V. | 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives |
| DE3442757A1 (de) * | 1984-11-23 | 1986-05-28 | Wella Ag, 6100 Darmstadt | Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate |
| KR930005004B1 (ko) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
| FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
| FR2702214B1 (fr) * | 1993-03-05 | 1995-04-14 | Adir | Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
| GB9418326D0 (en) * | 1994-09-12 | 1994-11-02 | Lilly Industries Ltd | Pharmaceutical compounds |
| EP0705832B1 (en) | 1994-09-12 | 2003-08-13 | Eli Lilly And Company Limited | Serotonergic modulators |
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
| GB9613423D0 (en) * | 1996-06-26 | 1996-08-28 | Lilly Industries Ltd | Pharmaceutical compounds |
| EP2392584A1 (en) * | 2006-09-19 | 2011-12-07 | Cipla Limited | Crystalline Ciclesonide Methanol Solvate Form C |
| CN101759693B (zh) * | 2008-12-23 | 2011-09-14 | 江苏恩华药业股份有限公司 | 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用 |
| WO2022195102A1 (en) * | 2021-03-19 | 2022-09-22 | Centre National De La Recherche Scientifique | Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633495A (pl) * | 1962-06-13 | |||
| US3225052A (en) * | 1964-05-06 | 1965-12-21 | Janssen Pharmaceutica Nv | Benzimidazolinyl piperidine derivatives |
| FR1573739A (pl) | 1968-07-26 | 1969-07-04 | ||
| US3647790A (en) * | 1969-04-08 | 1972-03-07 | American Home Prod | Ouinoxalinyl-oxazolidines and -oxazines |
-
1976
- 1976-08-10 US US05/713,309 patent/US4035369A/en not_active Expired - Lifetime
- 1976-09-22 NZ NZ182134A patent/NZ182134A/xx unknown
- 1976-09-23 AU AU18078/76A patent/AU511834B2/en not_active Expired
- 1976-09-28 PH PH18950A patent/PH15417A/en unknown
- 1976-10-01 CA CA262,478A patent/CA1085853A/en not_active Expired
- 1976-10-05 FR FR7629928A patent/FR2346009A1/fr active Granted
- 1976-10-05 GR GR51849A patent/GR61672B/el unknown
- 1976-10-05 EG EG605/76A patent/EG12969A/xx active
- 1976-10-06 IT IT51612/76A patent/IT1069293B/it active
- 1976-10-06 CH CH1265376A patent/CH630915A5/de not_active IP Right Cessation
- 1976-10-06 GB GB41465/76A patent/GB1532546A/en not_active Expired
- 1976-10-06 DE DE19762645125 patent/DE2645125A1/de active Granted
- 1976-10-07 FI FI762865A patent/FI63228C/fi not_active IP Right Cessation
- 1976-10-07 PT PT65688A patent/PT65688B/pt unknown
- 1976-10-07 LU LU75954A patent/LU75954A1/xx unknown
- 1976-10-07 SE SE7611137A patent/SE417610B/xx not_active IP Right Cessation
- 1976-10-07 IE IE2212/76A patent/IE43951B1/en unknown
- 1976-10-07 ES ES452200A patent/ES452200A1/es not_active Expired
- 1976-10-07 NO NO763424A patent/NO144926C/no unknown
- 1976-10-07 IL IL50631A patent/IL50631A/xx unknown
- 1976-10-07 NL NL7611085A patent/NL7611085A/xx not_active Application Discontinuation
- 1976-10-07 DK DK452076A patent/DK151801C/da not_active IP Right Cessation
- 1976-10-07 JP JP51119933A patent/JPS5246082A/ja active Granted
- 1976-10-07 PL PL1976192890A patent/PL106815B1/pl not_active IP Right Cessation
- 1976-10-07 AT AT0745276A patent/AT365185B/de active
- 1976-10-08 RO RO197687960Q patent/RO69904A/ro unknown
- 1976-10-08 HU HU76JA771A patent/HU174927B/hu not_active IP Right Cessation
- 1976-10-08 SU SU762407707A patent/SU663306A3/ru active
- 1976-10-08 CS CS766511A patent/CS225101B2/cs unknown
- 1976-10-08 YU YU2480/76A patent/YU39976B/xx unknown
- 1976-10-08 BG BG7634394A patent/BG27542A3/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL194291A1 (pl) | Sposob wytwarzania nowych pochodnych glikozoaminy | |
| PL100792B1 (pl) | Sposob wytwarzania nowych pochodnych tienopirydyny | |
| PL201286A1 (pl) | Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow | |
| PL192890A1 (pl) | Sposob wytwarzania nowych 1-benzazoliloalkilo-4-podstawowych piperydyn | |
| PL193761A1 (pl) | Sposob wytwarzania czteropierscieniowych chinonow | |
| PL193183A1 (pl) | Sposob wytwarzania nowych pochodnych 11-dezoksy-16-arylo-omega-tetranorprostaglandyny | |
| PL193861A1 (pl) | Sposob wytwarzania alfa-aminoketonow | |
| PL192020A1 (pl) | Sposob wytwarzania n-tetrahydrofurfurylo-noroksymorfonow | |
| TR19184A (tr) | Usul | |
| PL192578A1 (pl) | Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow | |
| PL200534A1 (pl) | Sposob wytwarzania nowych oksadeztiacefalosporyn | |
| PL190247A1 (pl) | Sposob wytwarzania nowych podstawionych heterocyklicznych n-alkanoloamin | |
| PL192253A1 (pl) | Sposob wytwarzania nowych pochodnych neaminy | |
| PL191156A1 (pl) | Sposob wytwarzania nowych epoksyandrostanow | |
| PL96241B1 (pl) | Sposob wytwarzania 2-/2-podstawionych-4-tiazolilo/-benzimidazoli | |
| PL100616B1 (pl) | Sposob wytwarzania nowych eterowych pochodnych oksymu | |
| PL201133A1 (pl) | Sposob wytwarzania nowych pirydobenzodwuazepinonow | |
| PL193604A1 (pl) | Sposob wytwarzania nowych d-homosteroidow | |
| PL100145B1 (pl) | Sposob wytwarzania nowych zwiazkow dwuureidowych | |
| PL190303A1 (pl) | Sposob wytwarzania nowych enamin | |
| PL191309A1 (pl) | Sposob wytwarzania nowych pochodnych 1-(benzazolilo-alkilo)-piperydyny | |
| SE417963B (sv) | Forfarande for framstellning av metyl-6-n-propoxibensotiazol-2-karbamat | |
| PL193219A1 (pl) | Sposob wytwarzania nowych aminoglikozydow 2-dezoksystreptaminy | |
| PL98457B1 (pl) | Sposob wytwarzania nowych chloroarylofosforanow | |
| PL94616B1 (pl) | Sposob wytwarzania metyloheptenonu-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20031220 |